Urte Jakimaviciute, MSc, is Senior Director of Market Research and Strategic Intelligence in the healthcare division at GlobalData, London. Her primary responsibility includes managing the market research process for the syndicated portfolio and custom consulting projects, as well as managing strategic research portfolio. Urte has over 15 years of experience in pharmaceutical market research industry. Prior to GlobalData, she held management roles at market research agencies providing consulting and market research services to the healthcare and technology industries.
Urte holds a MS in Economics from the LUISS Guido Carli University, Italy and a BA in Information Management Systems from Vilnius University, Lithuania.
Digital innovation business leader with vision for turning bold technology innovations into operational realities.
As Emerging Technologies Director I am accountable for the collaboration with cross functional business partners in managing the delivery of promoting solutions between test/start/scale. I am accountable for understanding the demands and implications of solutions and will ensure that the organisation has the capability and capacity to achieve business outcomes with agreement and clarity around roles and responsibility. My role is to forge relationships with internal and external partners to build best practice and establish new ways of working.
My mission is to introduce innovative technologies in AstraZeneca clinical trials, paving the way towards operational excellence.
Joachim Lövin has worked in the pharmaceutical industry for over 20 years across various therapeutic areas and organizations. During this time, Joachim has worked in different roles spanning over Data Management, Project Management, Process Development, Senior Business Analyst and Clinical Operations. In his current role as DCT Specialist, Joachim focuses on supporting trials including competence development of Clinical Operations, identifying opportunities, and operationalising Decentralised Clinical Trial Elements across Novo Nordisk. Joachim is the Workstream Lead for the Modernizing Clinical Trial Conduct workstream for TransCelerate Biopharma, and a member of the eClinical Forums Trial of the Future. All of Joachim’s work is aligned with his passion to improve patient experience and accelerating clinical trials.
Global pharmaceutical, OMP and pediatric EU legislation. Rare diseases policies . Gene Therapy-ATMP . HTA and access frameworks. Cross border access. Patient engagement. Incentives for medicine development. Repurposing.
– All aspects of medical affairs across the product life cycle – Compassionate Use and Medical Need programs. Diagnostics. Real world evidence and registries
– Multistakeholder engagement
I’m a generalist in a highly specialised environment and a Medical Doctor with over 25 years experience primarily in biotechnology and innovative pharmaceutical companies.
Strong international experience in medical and policy departments collaborate across functions and across stakeholders.
Experienced Patient Advocate active as a volunteer in the non-profit sector in Europe focused on rare diseases and especially rare eye disease. Background in finance and business strategy. Healthcare is in crisis and we need to collaborate to make things better – researchers, clinicians, regulators, payers, industry and patients, we all need to play our part. And across borders too – separatist nonsense like Brexit does not make anything better and we have to expend additional scarce resource to try and overcome the problems it creates
Biography
Nick De Donder graduated as a biomedical scientist from the University of Ghent, Belgium in 2007 and has been employed since 2008 by Business & Decision Life Sciences at their headquarters in Brussels. He has been moving from being a Data Integration Specialist to Project Manager to Line Manager for the Data Standards team. Since 2020 he is Head of Data Standards. Nick is a member of the SDS team, an authorized CDISC trainer for CDASH, SDTM and Newcomers and a PHUSE committee member since 2017. In 2019 he joined the E3C and is now co-chairing it. Since June 2021 Nick has been product owner of the CORE application.
Momna Ali, MSc, is an Analyst at GlobalData’s London office with the Neurology and Immunology teams. She is involved in the production of opportunity assessment and forecasting reports as well as competitive landscape analysis reports, for neuroimmunology-related areas. Additionally, Momna previously worked in a clinical research organization (CRO), managing their medical devices and cardio systems portfolio. Prior to that role, she worked as senior immunizations officer with NHS (National Health Service) England. Momna holds a Master’s of Science in Health Management from City University of London, and a Bachelor’s degree in Biomedical Science from Middlesex, University of London.
